Transcatheter aortic valve replacement (TAVR) market is expected to reach USD 6.03 Billion by 2023
Transcatheter Aortic Valve Replacement (TAVR) Market by Surgery Method, Valve Frame Material, Valve Size, Valve Leaflets Material, and End Users- Global Market Analysis, Size, Geographic Regional Analysis.
(EMAILWIRE.COM, October 01, 2018 ) Market Overview:
Global Transcatheter aortic valve replacement (TAVR) market is estimated at USD 2.58 Billion in 2018, and is expected to reach USD 6.03 Billion by 2023 with a CAGR of 18.50%. Transcatheter aortic valve implantation (TAVI), also known as as transcatheter aortic valve replacement (TAVR), is a minimally invasive operation, that is performed to treat risky patients affected by aortic stenosis. These risky patients refer to the patient population that square measure inoperable and can't bear surgical aortic valve replacement (SAVR) procedure. Older population (above seventy five years of age) falls under the risky class, because the open-heart procedure is too risky for them.
Request Report Sample https://www.marketdataforecast.com/market-reports/transcatheter-aortic-valve-replacement-market-357/request-sample
Factors affecting market growth:
• Increased funding for Research and Development (+)
• Rise in geriatric population (+)
• Advancements in technology and increase in adoption rate (+)
• Rise in awareness (+)
• High cost for treatments (-)
• Lack of skilled professionals in certain regions (-)
• Device related issues (-)
Get your customized report: https://www.marketdataforecast.com/market-reports/transcatheter-aortic-valve-replacement-market-357/customize-report
Market Segmentation
Transcatheter aortic valve replacement (TAVR) market is geographically segmented into
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
North America is estimated to command the highest share of 34% of the global transcatheter aortic valve replacement (TAVR) market in 2018, whereas Asia-Pacific is estimated to grow at the highest CAGR of 21.20% during the forecast period 2018-2023.
Browse full Table of Contents: https://www.marketdataforecast.com/market-reports/transcatheter-aortic-valve-replacement-market-357/
Key players:
Edwards Life sciences Corporation (U.S.), Medtronic, Inc. (Ireland), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), St. Jude Medical Inc. (U.S.), JenaValve Technology, Inc. (Germany), Symetis SA (Switzerland), Direct Flow Medical, Inc. (U.S.), Sorin Group (Italy), Meril Life Sciences India Pvt Ltd (India), and Braile Biomedica (Brazil).
Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank, B-44, Rd Number 3, Journalist Colony, Film Nagar, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
Global Transcatheter aortic valve replacement (TAVR) market is estimated at USD 2.58 Billion in 2018, and is expected to reach USD 6.03 Billion by 2023 with a CAGR of 18.50%. Transcatheter aortic valve implantation (TAVI), also known as as transcatheter aortic valve replacement (TAVR), is a minimally invasive operation, that is performed to treat risky patients affected by aortic stenosis. These risky patients refer to the patient population that square measure inoperable and can't bear surgical aortic valve replacement (SAVR) procedure. Older population (above seventy five years of age) falls under the risky class, because the open-heart procedure is too risky for them.
Request Report Sample https://www.marketdataforecast.com/market-reports/transcatheter-aortic-valve-replacement-market-357/request-sample
Factors affecting market growth:
• Increased funding for Research and Development (+)
• Rise in geriatric population (+)
• Advancements in technology and increase in adoption rate (+)
• Rise in awareness (+)
• High cost for treatments (-)
• Lack of skilled professionals in certain regions (-)
• Device related issues (-)
Get your customized report: https://www.marketdataforecast.com/market-reports/transcatheter-aortic-valve-replacement-market-357/customize-report
Market Segmentation
Transcatheter aortic valve replacement (TAVR) market is geographically segmented into
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
North America is estimated to command the highest share of 34% of the global transcatheter aortic valve replacement (TAVR) market in 2018, whereas Asia-Pacific is estimated to grow at the highest CAGR of 21.20% during the forecast period 2018-2023.
Browse full Table of Contents: https://www.marketdataforecast.com/market-reports/transcatheter-aortic-valve-replacement-market-357/
Key players:
Edwards Life sciences Corporation (U.S.), Medtronic, Inc. (Ireland), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), St. Jude Medical Inc. (U.S.), JenaValve Technology, Inc. (Germany), Symetis SA (Switzerland), Direct Flow Medical, Inc. (U.S.), Sorin Group (Italy), Meril Life Sciences India Pvt Ltd (India), and Braile Biomedica (Brazil).
Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank, B-44, Rd Number 3, Journalist Colony, Film Nagar, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results